Systematic Analysis of Multiple Imaging Modalities in Infants Diagnosed with Mucopolysaccharidosis by Newborn

Chung-Lin Lee1,2,3,4,5, Szu-Wen Chang1, Hung-Hsiang Fang1,6

  • 1Department of Pediatrics, MacKay Memorial Hospital, Taipei 10449, Taiwan.

Insights

Newborn screening detects mucopolysaccharidosis (MPS) abnormalities before symptoms appear. Comprehensive imaging and biochemical marker correlations aid early diagnosis and monitoring of these rare genetic disorders.

Area of Science:

  • Medical Genetics
  • Pediatric Radiology
  • Lysosomal Storage Disorders

Background:

  • Mucopolysaccharidosis (MPS) comprises progressive genetic disorders impacting multiple organ systems.
  • Early detection via newborn screening is crucial, yet pre-symptomatic imaging assessment is not well-defined.
  • This study focuses on identifying early imaging markers in screen-positive infants.

Purpose of the Study:

  • To analyze skeletal, cardiac, and abdominal imaging findings in infants diagnosed with MPS via newborn screening.
  • To establish an integrated imaging assessment model for early-stage MPS.
  • To correlate imaging findings with biochemical markers for enhanced diagnostic insights.

Main Methods:

  • Retrospective analysis of 277 screen-positive MPS cases (MPS I, II, IVA, VI) from 2015-2024.
  • Standardized skeletal radiography, cardiac, and abdominal ultrasonography were performed.
  • Imaging data were analyzed alongside biochemical markers and clinical parameters.

Main Results:

  • Cardiac abnormalities (e.g., ASD/PFO) were most frequent in MPS I (33.3%).
  • Vertebral changes were more common in MPS IVA (16.5%) and MPS II (15.9%).
  • Significant correlations found between vertebral issues and keratan sulfate, cardiac issues and dermatan sulfate, and abdominal findings and enzyme activity/DBU ratios.

Conclusions:

  • Significant presymptomatic abnormalities in MPS infants can be detected through comprehensive imaging.
  • Correlations between imaging and biochemical markers offer novel insights for early diagnosis and monitoring.
  • Implementing integrated imaging protocols for screen-positive cases is recommended.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...